Intravitreal bevacizumab and ranibizumab injections for patients with polypoidal choroidal vasculopathy

類似資料

• Short-term Effectiveness of Intravitreal Bevacizumab vs. Ranibizumab Injections for Patients with Polypoidal Choroidal Vasculopathy
  著者:: Cho, Han Joo, 等
  出版事項: (2012)
• Intravitreal ranibizumab injection combined with photodynamic therapy for polypoidal choroidal vasculopathy
  著者:: Li, Jia, 等
  出版事項: (2018)
• Treatment of polypoidal choroidal vasculopathy with intravitreal bevacizumab monotherapy
  著者:: Tan, Colin S H, 等
  出版事項: (2013)
• Effects of three consecutive monthly intravitreal injection of ranibizumab for polypoidal choroidal vasculopathy in Korea
  著者:: Park, Young Gun, 等
  出版事項: (2015)
• Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
  著者:: Sonoda, Shozo, 等
  出版事項: (2013)